Sistema de Fluidos de Microencapsulación

Ficha

Fechas

Publicada25 sep 2026Cierre de ofertas29 sep 2026 · 16:00 (hora de UTC)

Descripción oficial

1.0 DESCRIPTION This is a Combined Synopsis/Solicitation for commercial products and commercial services conducted in accordance with RFO FAR Part 12, Acquisition of Commercial Products and Commercial Services, using the simplified procedures applicable to commercial products and commercial services. This notice constitutes the solicitation. Quotations are requested, and a separate written solicitation will not be issued. The National Institute of Environmental Health Sciences (NIEHS), Division of Translational Toxicology (DTT), Mechanistic Toxicology Branch (MTB), intends to acquire a commercially available microencapsulation fluidics system, including the required microfluidic modules, pumping and droplet-generation components, computer and software, installation, and training. The Government is seeking a commercially available system that meets the functional, performance, and operational requirements described in the attached Requirements Document. The Government will consider quotations for the named product as well as products offered by other manufacturers that demonstrate compliance with all stated requirements. The Government's requirement is based on the functional and performance characteristics necessary to support the intended scientific application and is not restricted to a particular manufacturer, make, or model. The Government requires a specialized microencapsulation fluidics platform capable of combining liquid-form alginate with human cell suspensions under controlled conditions and generating droplets that form alginate capsules around suspension cells. The system will support the formation of three-dimensional (3D) microtissues, organoids, spheroids, and other advanced cell models for translational toxicology applications. The required system shall provide controlled microfluidic pumping and droplet-generation capabilities suitable for the Government's intended application. The system shall permit reliable and reproducible combination of alginate and human cell suspensions and generation of appropriately sized droplets under controlled operating conditions. The requirement includes the system hardware, applicable control equipment, computer and software necessary for operation, installation, and user training. Installation and training shall be performed at the NIEHS facility and shall include sufficient instruction to enable designated laboratory personnel to operate the system and perform the required microencapsulation procedures. The system shall operate independently of NIEHS information technology systems and shall not require integration with NIEHS enterprise information technology infrastructure. Acceptance shall be based on the Government's determination that the delivered system has been installed and configured in accordance with the solicitation requirements and is capable of performing the specified microencapsulation process. Acceptance may include demonstration of successful formation of alginate-encapsulated

Cómo participar

1. Registra tu empresa en SAM.gov (es gratis) para obtener el identificador único de entidad (UEI). La mayoría de las solicitudes exigen el registro activo al presentar la oferta, y el trámite puede tardar varias semanas.
2. Abre el aviso en SAM.gov y lee la solicitud, sus anexos y cada enmienda.
3. Presenta tu oferta exactamente como indica el aviso, antes de la fecha de respuesta.